The Clinical and Subjective Performance of Three Different MPDS With Silicon Hydrogel Lenses
The Evaluation of the Clinical and Subjective Performance of Three Different Contact Lens Care Solutions With Silicon Hydrogel Lenses
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of the clinical investigation is to assess the clinical and subjective performance of three novel multipurpose disinfecting solutions (MPDS) in daily wear with two silicone hydrogel contact lenses (Lotrafilcon B and Comfilcon A).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 8, 2012
CompletedFirst Posted
Study publicly available on registry
August 15, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedMarch 6, 2015
March 1, 2015
2.4 years
August 8, 2012
March 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical performance
TBUT, conjunctival and limbal hyperemia, corneal vascularization, epithelial and stromal oedema, corneal infiltrates, endothelial regularity, corneal staining and papillar conjunctivitis
1 month
Secondary Outcomes (1)
Subjective performance
1 month
Study Arms (3)
MPDS1
EXPERIMENTALContact lens care solution
MPDS2
ACTIVE COMPARATORContact lens care solution
MPDS3
ACTIVE COMPARATORContact lens care solution
Interventions
Comparison of clinical and subjective performation of the contact lens care solutions used with two types of contact lenses
Eligibility Criteria
You may qualify if:
- age above 18
- experienced contact lens user
- good health (self-reported)
You may not qualify if:
- eye disease or eye operations
- pregnancy
- medication that can affect sight
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Finnsusp Ltd.lead
Study Sites (1)
Raision Näkökulma
Raisio, Finland
Study Officials
- STUDY DIRECTOR
Riikka Järvinen, PhD
University of Turku, Finland; Finnsusp Ltd, Finland
- PRINCIPAL INVESTIGATOR
Hanna Vaahtoranta-Lehtonen, Dr. Ophth.
Turku University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2012
First Posted
August 15, 2012
Study Start
August 1, 2012
Primary Completion
January 1, 2015
Last Updated
March 6, 2015
Record last verified: 2015-03